EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Risk factors diagnosis prognosis and treatment of autism

Meghan Styles, Dalal Alsharshani, Muthana Samara, Mohammed Alsharshani, Azhar Khattab, M Walid Qoronfleh, Nader Izzeddin Al-Dewik

Frontiers in Bioscience · 2020 · 25 (9) · 1682-1717

DOI: 10.2741/4873 ↗

At a glance

Übersichtsarbeit in Frontiers in Bioscience, 2020. Written by Meghan Styles and 6 co-authors. Institution: Health Profession Awareness Program, Health Facilities Development, Hamad Medical Corporation (HMC), Doha, Qatar. Major MEDLINE topics: Genetic Heterogeneity, Mutation. Cited 70 times so far (Crossref).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The prevalence rate of Autism Spectrum Disorder (ASD) has reached over 1% world-wide prompting governments, health providers and schools to develop programs and policies to address this challenging disorder. Here, we review the cause(s), as well as environmental factors, genetic mutations, and neural pathways that are implicated in ASD. We also discuss the criteria that are commonly used for the diagnosis of ASD and future clinical genetic testing that can aid in the diagnosis of this disorder. Finally, we provide practical steps that can be used to reduce the incidence and severity of ASD, as well as prognosis and treatment of autism.

Subjects

MeSH terms (MEDLINE)

Genetic HeterogeneityMutationAutistic DisorderCalcium-Binding ProteinsCell Adhesion Molecules, NeuronalGenetic Predisposition to DiseaseHumansMembrane ProteinsNerve Tissue ProteinsNeural Cell Adhesion MoleculesPrognosisRisk FactorsSignal Transduction

Substances

Calcium-Binding ProteinsCell Adhesion Molecules, NeuronalMembrane ProteinsNRXN1 protein, humanNerve Tissue ProteinsNeural Cell Adhesion Moleculesneuroligin 3

Authors and institutions

  • Health Profession Awareness Program, Health Facilities Development, Hamad Medical Corporation (HMC), Doha, Qatar.
  • Precision Medicine, College of Science and Engineering, Hamad Bin Khalifa University (HBKU), Doha, Qatar.
  • Developmental Psychology Research Group, Department of Psychology, Kingston University-London, Kingston upon Thames, Surrey, United Kingdom.
  • Molecular Genetics Laboratory, Hamad Medical Corporation (HMC), Doha, Qatar.
  • Qatar Rehabilitation Institute (QRI), Hamad Medical Corporation (HMC), Doha, Qatar.
  • Research & Policy Department, World Innovation Summit for Health (WISH), Qatar Foundation, P.O. Box 5825, Doha, Qatar.

Cite

APA

Styles, M., Alsharshani, D., Samara, M., Alsharshani, M., Khattab, A., Qoronfleh, M. W., & Al-Dewik, N. I. (2020). Risk factors diagnosis prognosis and treatment of autism. Frontiers in Bioscience, 25(9), 1682-1717. https://doi.org/10.2741/4873

Vancouver

Styles M, Alsharshani D, Samara M, Alsharshani M, Khattab A, Qoronfleh MW, et al. Risk factors diagnosis prognosis and treatment of autism. Frontiers in Bioscience. 2020;25(9):1682-1717. doi:10.2741/4873

BibTeX
@article{Styles2020,
  author = {Styles, Meghan and Alsharshani, Dalal and Samara, Muthana and Alsharshani, Mohammed and Khattab, Azhar and Qoronfleh, M Walid and Al-Dewik, Nader Izzeddin},
  title = {Risk factors diagnosis prognosis and treatment of autism},
  journal = {Frontiers in Bioscience},
  year = {2020},
  volume = {25},
  number = {9},
  pages = {1682--1717},
  doi = {10.2741/4873}
}
Start for free →